use the source below and answer the following 3 questions

Source:

Schneider, K. 1983. Faking it: The Case against Industrial Bio-Test Laboratories. The Amicus Journal. [accessed 2023 March 8]. 

Questions:

1. What are your thoughts on how the FDA and the government could have handled this matter differently?
2. If you are in the position of Dr. Philip Smith, the IBT technician, how could you have handled a situation like this?
3. What are some Good Laboratory Practices that could have been implemented in IBT labs?

Using these sources answer the 3 questions:

CBC. A look back at Canada’s tainted blood scandal. 2013 Oct 4. [accessed 2023 Feb 18]; [6 paragraphs]. 

Picard A. 2017 Nov 28. Have we forgotten the lessons of the tainted blood scandal? [accessed 2023 Feb 18]; [10 points]. 

Sher G. 2019 Jan 9. Today’s blood system: no longer unsafe or “unspeakable”. [accessed 2023 Feb 18]; [7 paragraphs]. 

Spurgeon D. 2005. Canadian Red Cross apologised for distributing HIV infected blood. BMJ. [accessed 2023 Feb 18]; 330(7504): 1349. Doi: 10.1136/bmj.330.7504.1349-a 

1. Do you think there should have been more consequences for the Canadian Red Cross? What are your thoughts on what was imposed or what else would you have wanted to happen?
2. How do you think the shortfalls and errors made by the Canadian Red Cross could have been prevented?
3. Do you think the Canadian Red Cross handled the situation well? What should they have done differently?

Using the sources below answer the 3 questions. 

• United States Department of Justice. 2007. Four Managers of Now-Defunct N.J. Generic Drug Maker Admit Fraud that Led to Collapse and Bankruptcy of Company. [online] Available from:  Accessed 2023, Feb 19.
• Taylor, N. 2012. [online] Outsourcing Pharma. Available from:  Accessed 2023, Feb 19.

Questions:

1) Is there anything Able Labs could have done to prevent this, yes or no? explain your thoughts. 

2) Why is this scandal important? in your opinion 

3) What do you think was the root cause of the Able Laboratory scandal? 

Using the following sources answer the following questions

Questions:

1. What preventative actions could GlaxoSmithKline have taken/implemented to prevent these compliance issues?
2. What could have been the result if Cheryl Eckard’s concerns were heard and acted upon when she first warned the company about the ongoing issues?
3. Why do you think the company decided to hide their mistakes and continue to produce/sell contaminated products? What advantage could they have had by producing adulterated drugs?

References:

Cette, D. CBS. 2010 Dec 29. Glaxo Whistle-Blower Lawsuit: Bad Medicine. Cbsnewscom. [accessed 2023 Feb 25] 

Harris G, Wilson D. 2010 Oct 26. Glaxo to Pay $750 Million for Sale of Bad Products. The New York Times. [accessed 2023 Feb 25] 

Wearden, G. 2010 Oct 27. GlaxoSmithKline whistleblower awarded $96m payout. the Guardian. [accessed 2023 Feb 25]